您的购物车当前为空
DPP-4-IN-13 (compound 9i) 作为竞争性DPP4抑制剂,展现出9.25 μM的IC50,适于2型糖尿病研究应用。

DPP-4-IN-13 (compound 9i) 作为竞争性DPP4抑制剂,展现出9.25 μM的IC50,适于2型糖尿病研究应用。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
DPP-4-IN-13 相关产品
| 产品描述 | DPP-4-IN-13 (compound 9i) is a competitive inhibitor of DPP4, exhibiting an IC50 of 9.25 μM, making it suitable for research in type 2 diabetes. |
| 分子量 | 571.85 |
| 分子式 | C25H24BrClN6O3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容